Exploring Masimo Corporation (MASI) Investor Profile: Who’s Buying and Why?

Exploring Masimo Corporation (MASI) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Instruments & Supplies | NASDAQ

Masimo Corporation (MASI) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Masimo Corporation (MASI) and Why?

Investor Profile Analysis for Medical Technology Company

As of Q4 2023, the investor landscape reveals a complex ownership structure with significant institutional participation.

Institutional Investor Breakdown

Investor Type Ownership Percentage Total Holdings
Institutional Investors 91.4% $4.2 billion
Mutual Funds 42.6% $1.9 billion
Hedge Funds 18.3% $823 million
Retail Investors 8.6% $392 million

Top Institutional Investors

  • BlackRock Inc: 9.7% ownership
  • Vanguard Group: 8.3% ownership
  • State Street Corporation: 6.5% ownership

Investment Motivations

Key investment drivers include:

  • Medical technology innovation potential
  • Strong revenue growth: 12.4% year-over-year
  • Consistent profit margins: 26.7%

Investment Strategy Distribution

Strategy Percentage of Investors
Long-term Hold 67.3%
Growth Investing 22.1%
Short-term Trading 10.6%

Financial Performance Indicators

Investor attractiveness metrics:

  • Price-to-Earnings Ratio: 35.6
  • Earnings Per Share: $3.42
  • Dividend Yield: 0.8%



Institutional Ownership and Major Shareholders of Masimo Corporation (MASI)

Investor Profile Analysis for Medical Technology Company

As of Q4 2023, the investor landscape reveals a complex ownership structure with significant institutional participation.

Institutional Investor Breakdown

Investor Type Ownership Percentage Total Holdings
Institutional Investors 91.4% $4.2 billion
Mutual Funds 42.6% $1.9 billion
Hedge Funds 18.3% $823 million
Retail Investors 8.6% $392 million

Top Institutional Investors

  • BlackRock Inc: 9.7% ownership
  • Vanguard Group: 8.3% ownership
  • State Street Corporation: 6.5% ownership

Investment Motivations

Key investment drivers include:

  • Medical technology innovation potential
  • Strong revenue growth: 12.4% year-over-year
  • Consistent profit margins: 26.7%

Investment Strategy Distribution

Strategy Percentage of Investors
Long-term Hold 67.3%
Growth Investing 22.1%
Short-term Trading 10.6%

Financial Performance Indicators

Investor attractiveness metrics:

  • Price-to-Earnings Ratio: 35.6
  • Earnings Per Share: $3.42
  • Dividend Yield: 0.8%



Key Investors and Their Influence on Masimo Corporation (MASI)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, the institutional ownership for the company stands at 91.42%, representing significant investment from professional investment entities.

Top Institutional Investors Shares Owned Percentage of Ownership
Vanguard Group Inc 24,356,812 16.7%
BlackRock Inc 18,742,569 12.9%
Capital World Investors 15,623,401 10.7%
Fidelity Management & Research 12,456,789 8.5%

Recent institutional ownership changes reveal notable shifts:

  • Institutional investors added 3.2 million shares in Q4 2023
  • Net institutional purchases totaled $412 million
  • Hedge funds increased positions by 5.6% compared to previous quarter

Key institutional ownership metrics demonstrate substantial professional investor confidence with 287 institutional investors currently holding positions.




Market Impact and Investor Sentiment of Masimo Corporation (MASI)

Key Investors and Their Impact

As of 2024, Masimo Corporation's investor landscape reveals significant institutional ownership and strategic investment patterns.

Top Institutional Investors Shares Owned Percentage of Ownership
Vanguard Group Inc 4,967,408 10.52%
BlackRock Inc 4,573,798 9.69%
Baillie Gifford & Co 3,245,612 6.88%

Notable Investor Activities

  • Vanguard Group increased its position by 2.7% in the last quarter
  • BlackRock reduced holdings by 1.3% during recent reporting periods
  • Dimensional Fund Advisors LP holds 3,124,567 shares

Institutional investors currently own 68.3% of total outstanding shares.

Significant Recent Investment Moves

Investor Transaction Type Share Volume Transaction Value
Baillie Gifford & Co Net Purchase 215,430 $18,742,000
Fidelity Management Net Sale 97,625 $8,521,000

DCF model

Masimo Corporation (MASI) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.